1. Effects of Megaplasmid Loss on Growth of Neurotoxigenic Clostridium butyricum Strains and Botulinum Neurotoxin Type E Expression
    Concetta Scalfaro et al, 2016, Front. Microbiol. CrossRef
  2. Myeloid zinc finger 1 mediates sulindac sulfide-induced upregulation of death receptor 5 of human colon cancer cells
    Mano Horinaka et al, 2015, Sci Rep CrossRef
  3. Antiproliferative Effects of Bacillus coagulans Unique IS2 in Colon Cancer Cells
    Ratna Sudha Madempudi et al, 2017, Nutrition and Cancer CrossRef
  4. Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union
    Theodor Brodmann et al, 2017, Front. Microbiol. CrossRef
  5. Probiotic Modulation of Innate Cell Pathogen Sensing and Signaling Events
    Amy Llewellyn et al, 2017, Nutrients CrossRef
  6. Comparison of matrix proteinase mRNA expression in morphologically normal, neoplastic, and metastatic colon tissue and colon biopsies from healthy donors
    V.K. Bozhenko et al, 2018, Biomed Khim CrossRef
  7. Dietary Clostridium Butyricum induces a phased shift in fecal microbiota structure and increases the acetic acid-producing bacteria in a weaned piglet model
    Jie Zhang et al, 2018, J. Agric. Food Chem. CrossRef
  8. Tumour-targeting bacteria engineered to fight cancer
    Shibin Zhou et al, 2018, Nat Rev Cancer CrossRef
  9. null
    Dinesh Kumar Dahiya et al, 2019 CrossRef
  10. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics
    Paul W. O’Toole et al, 2017, Nat Microbiol CrossRef
  11. The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies
    Jun Gong et al, 2019, Clin Trans Med CrossRef
  12. The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing
    Tianyu Liu et al, 2019, Int. J. Cancer CrossRef
  13. Clostridium butyricum pretreatment attenuates cerebral ischemia/reperfusion injury in mice via anti-oxidation and anti-apoptosis
    Jing Sun et al, 2016, Neuroscience Letters CrossRef
  14. Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota
    Jing Sun et al, 2016, Brain Research CrossRef
  15. The Potential Role of Probiotics in Cancer Prevention and Treatment
    Ai-Qun Yu et al, 2016, Nutrition and Cancer CrossRef
  16. Controversial roles played by toll like receptor 4 in urinary bladder cancer; A systematic review
    Amin Afsharimoghaddam et al, 2016, Life Sciences CrossRef
  17. The Role of MMP8 in Cancer: A Systematic Review
    null Juurikka et al, 2019, IJMS CrossRef
  18. Clostridium tyrobutyricum alleviates Staphylococcus aureus-induced endometritis in mice by inhibiting endometrial barrier disruption and inflammatory response
    Xiaoyu Hu et al, 2019, Food Funct. CrossRef
  19. The Role of TRAIL/DRs in the Modulation of Immune Cells and Responses
    Duygu Sag et al, 2019, Cancers CrossRef
  20. Matrix metalloproteinases in urinary system tumors. Part II - Matrix metalloproteinases in urinary bladder carcinoma
    G. Młynarczyk et al, 2017, Prog Health Sci CrossRef
  21. Bacteria-cancer interactions: bacteria-based cancer therapy
    Mai Thi-Quynh Duong et al, 2019, Exp Mol Med CrossRef
  22. TRAIL in oncology: From recombinant TRAIL to nano- and self-targeted TRAIL-based therapies
    Hassan Dianat-Moghadam et al, 2020, Pharmacological Research CrossRef
  23. Bacteria producing antimicrobials against Clostridium difficile isolated from human stool
    Rania Abdelmonem Khattab et al, 2020, Anaerobe CrossRef
  24. null
    Prashant Upadhaya et al, 2021 CrossRef
  25. Self-Propelled and Near-Infrared-Phototaxic Photosynthetic Bacteria as Photothermal Agents for Hypoxia-Targeted Cancer Therapy
    Pengli Zheng et al, 2020, ACS Nano CrossRef
  26. Tweak to Treat: Reprograming Bacteria for Cancer Treatment
    Brendan Fu-Long Sieow et al, 2020, Trends in Cancer CrossRef
  27. The Role of Probiotics in Cancer Prevention
    Katarzyna Śliżewska et al, 2020, Cancers CrossRef
  28. Bacteria-Mediated Synergistic Cancer Therapy: Small Microbiome Has a Big Hope
    Xinyu Lou et al, 2021, Nano-Micro Lett. CrossRef
  29. Genetically Engineered Bacterial Protein Nanoparticles for Targeted Cancer Therapy
    Haiyan Yang et al, 2021, IJN CrossRef
  30. Bacteria‐Based Cancer Immunotherapy
    Xuehui Huang et al, 2021, Adv. Sci. CrossRef
  31. Next-generation probiotics: a promising approach towards designing personalized medicine
    Tejinder Pal Singh et al, 2021, Critical Reviews in Microbiology CrossRef
  32. Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease.
    Magdalena K Stoeva et al, 2021, Gut Microbes CrossRef
  33. Microbial cancer therapeutics: A promising approach
    Deepti Diwan et al, 2021, Seminars in Cancer Biology CrossRef
  34. Administration of Lactobacillus reuteri Combined with Clostridium butyricum Attenuates Cisplatin-Induced Renal Damage by Gut Microbiota Reconstitution, Increasing Butyric Acid Production, and Suppressing Renal Inflammation
    Yu-Ping Hsiao et al, 2021, Nutrients CrossRef
  35. null
    Jung-Joon Min et al, 2021 CrossRef
  36. Engineering Cell‐Based Systems for Smart Cancer Therapy
    Nima Mirkhani et al, 2021, Advanced Intelligent Systems CrossRef
  37. The Role Played by Bacterial Infections in the Onset and Metastasis of Cancer
    Sajmina Khatun et al, 2021, Current Research in Microbial Sciences CrossRef
  38. Probiotics in Counteracting the Role of Neutrophils in Cancer Metastasis
    Upasana Mangrolia et al, 2021, Vaccines CrossRef
  39. Current status of intratumour microbiome in cancer and engineered exogenous microbiota as a promising therapeutic strategy
    Jiawen Chen et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  40. Innovative Approaches of Engineering Tumor-Targeting Bacteria with Different Therapeutic Payloads to Fight Cancer: A Smart Strategy of Disease Management
    Khaled S Allemailem, 2021, IJN CrossRef
  41. Bacteria and bacterial derivatives as delivery carriers for immunotherapy
    Sae-Ryung Kang et al, 2021, Advanced Drug Delivery Reviews CrossRef
  42. Bacteria therapeutics for cancer oncology: a crossroads for new paradigms
    Mayakrishnan Vijayakumar et al, 2022, Drug Discovery Today CrossRef
  43. Bacteria−Based Synergistic Therapy in the Backdrop of Synthetic Biology
    Yawei Bao et al, 2022, Front. Oncol. CrossRef
  44. A global bibliometric and visualized analysis of bacteria-mediated cancer therapy
    Jiawei Wang et al, 2022, Drug Discovery Today CrossRef
  45. Microbial hydrogen “manufactory” for enhanced gas therapy and self-activated immunotherapy via reduced immune escape
    Hongyu Yan et al, 2022, J Nanobiotechnol CrossRef
  46. The use of Clostridium in cancer therapy: a promising way
    Atieh Yaghoubi et al, 2022 CrossRef
  47. The impact of microbiota on PD-1/PD-L1 inhibitor therapy outcomes: A focus on solid tumors
    Sajad Najafi et al, 2022, Life Sciences CrossRef
  48. Utilizing Bacteria-Derived Components for Cancer Immunotherapy
    Chengxiao Zhang et al, 2022, BIO Integration CrossRef
  49. The relationship between Clostridium butyricum and colorectal cancer
    Hairong Liu et al, 2022, J Can Res Ther CrossRef
  50. The Role of the Gut Microbiome in Cancer Immunotherapy: Current Knowledge and Future Directions
    Despoina E. Kiousi et al, 2023, Cancers CrossRef
  51. Using bugs as drugs: administration of bacteria-related microbes to fight cancer
    Jiawei Wang et al, 2023, Advanced Drug Delivery Reviews CrossRef
  52. Intratumoural microbiota: from theory to clinical application
    Hao Ji et al, 2023, Cell Commun Signal CrossRef
  53. Clostridium Bacteria: The Team of Microscopic Oncologists
    Rosa Behboodi et al, 2023, Iranian Journal of Blood and Cancer CrossRef
  54. Bladder Cancer and Probiotics: What Do We Know So Far?
    Pedro Sánchez-Pellicer et al, 2023, Cancers CrossRef
  55. Association of Clostridium butyricum Therapy Using the Live Bacterial Product CBM588 with the Survival of Patients with Lung Cancer Receiving Chemoimmunotherapy Combinations
    Yusuke Tomita et al, 2023, Cancers CrossRef
  56. Role of probiotics in the management of cisplatin-induced nephrotoxicity
    Serina Easmin et al, 2024, Medicine in Microecology CrossRef
  57. The Potential of Clostridium butyricum to Preserve Gut Health, and to Mitigate Non-AIDS Comorbidities in People Living with HIV
    Qiyu Yang et al, 2024, Probiotics & Antimicro. Prot. CrossRef
  58. Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review)
    Jinzhe Sun et al, 2024, Int J Oncol CrossRef
  59. Hypoxia-Targeting Bacteria in Cancer Therapy
    Verena Staedtke et al, 2024, Seminars in Cancer Biology CrossRef
  60. Therapeutic bacteria and viruses to combat cancer: double-edged sword in cancer therapy: new insights for future
    Aref Yarahmadi et al, 2024, Cell Commun Signal CrossRef